Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
IEEE Transactions on Medical Imaging
|
July 19, 2021
Measuring Image Resolution in Ultrasound Localization Microscopy
V Hingot, A Chavignon, B Heiles, et al.
Biotechniques
|
November 1, 1988
In situ hybridization with digoxigenin-labeled DNA of human papillomaviruses (HPV 16/18) in HeLa and SiHa cells
H B Heiles, E Genersch, C Kessler, et al.
Acta Cytologica
|
November 1, 1986
Use of biotinylated DNA probes in screening cells obtained from cervical swabs for human papillomavirus DNA sequences
R Neumann, B Heiles, C Zippel, et al.
Geburtshilfe Und Frauenheilkunde
|
January 1, 1989
[Clinical relevance of nucleic acid detection of human papillomaviruses (HPV) in cells from smears of the cervix uteri]
R Neumann, H J Eggers, H H Zippel, et al.
Human Vaccines & Immunotherapeutics
|
December 7, 2017
Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
E D Moreira, A R Giuliano, J de Hoon, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
IEEE Transactions on Medical Imaging
|
July 19, 2021
Measuring Image Resolution in Ultrasound Localization Microscopy
V Hingot, A Chavignon, B Heiles, et al.
Biotechniques
|
November 1, 1988
In situ hybridization with digoxigenin-labeled DNA of human papillomaviruses (HPV 16/18) in HeLa and SiHa cells
H B Heiles, E Genersch, C Kessler, et al.
Acta Cytologica
|
November 1, 1986
Use of biotinylated DNA probes in screening cells obtained from cervical swabs for human papillomavirus DNA sequences
R Neumann, B Heiles, C Zippel, et al.
Geburtshilfe Und Frauenheilkunde
|
January 1, 1989
[Clinical relevance of nucleic acid detection of human papillomaviruses (HPV) in cells from smears of the cervix uteri]
R Neumann, H J Eggers, H H Zippel, et al.
Human Vaccines & Immunotherapeutics
|
December 7, 2017
Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
E D Moreira, A R Giuliano, J de Hoon, et al.
Page
of 1